Dr. Daniel Nagase, an emergency room doctor, working for various rural under-serviced communities throughout Alberta, was recently banned from medical practice after treating elderly severe COVID-19 patients with Ivermectin.
While the said patients successfully recovered, Nagase was still shortly removed from service due to “deliberately defying” the province’s COVID-19 treatment protocols. These protocols included the seemingly unwarranted prohibition of the prescription of Ivermectin, a drug that has been proven to be significantly effective against the virus.
Speaking on the steps of the Vancouver Art Gallery in an event observing the Nuremberg trials’ 75th anniversary, Nagase related that he has been serving as a doctor for the past 15 years. Although he lives in Vancouver, he served as an ER physician in several Alberta community medical centers for a decade.
The ER doctor stressed that the incident leading to his questionable ban from practicing medicine began on the weekend of September 11, when three elderly patients were rushed to the small rural hospital he was working in during his shift. He added that it was apparent that the patients were suffering from severe COVID-19 infection.
Besides administering inhalers, vitamins, and antibiotics, Nagase shared that he also gave the patients Ivermectin. Two of the three patients quickly recovered. According to the ER doctor for ten years, not even 24 hours after getting Ivermectin, “two out of my three patients were almost completely better.”
He added that they were “out of bed walking around.” Moreover, he also shared that “all the crackles I heard in their lungs from the day before were gone.” And Nagase stressed that all it took was “about 18 hours and one dose of Ivermectin.”
However, when the provincial health officials found out about his use of Ivermectin, Nagase was abruptly relieved of his duties. Central Zone medical director, Dr. Jennifer Bestard, called him up and informed him of his dismissal.
Despite Ivermectin’s proven therapeutic benefits regarding curbing the hyper-inflammatory phase of COVID, it is still ridiculed as “horse medicine” by most medical professionals allied with the U.S. government.
Many studies have already been conducted regarding the success of Ivermectin in treating COVID-19 patients, including those in the critical phase of infection. Still, it seems that most health agencies and organizations deliberately ignore its usefulness.
Some of the federal agencies that appear to keep Ivermectin’s potential as a COVID-19 treatment drug under the rug include the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the U.S. Food and Drug Administration (FDA).
The original video is attached below.